Antiviral drugs block replication of highly immune-evasive Omicron subvariants ex vivo, but fail to reduce tissue inflammation.
Dichtl S, Diem G, Jäger M, Zaderer V, Lupoli G, Dächert C, Muenchhoff M, Graf A, Blum H, Keppler OT, Lass-Flörl C, Weiss G, Wilflingseder D, Posch W.
Dichtl S, et al. Among authors: jager m.
Antiviral Res. 2023 May;213:105581. doi: 10.1016/j.antiviral.2023.105581. Epub 2023 Mar 23.
Antiviral Res. 2023.
PMID: 36965526
Free PMC article.